CIS Pharmaceutical Marketing Authorisation Course

Name: CIS Pharmaceutical Marketing Authorisation Strategy Course
Availability: InStock

Build jurisdiction-specific route maps, dossier controls, readiness reviews, authority-response workflows, and lifecycle governance for CIS markets.

CIS Pharmaceutical Marketing Authorisation Course

At a glance

Duration: 1 Week
Format: Classroom
Cities: Bali, London, Abu Dhabi, Muscat, Istanbul, Rome and more
Next session: 1 – 5 November 2026, Bali
Average fee: 5,750 €

Home
Our Categories
CIS Pharmaceutical Marketing Authorisation Strategy Course

Download Brochure (PDF) Print PDF

Overview

CIS Pharmaceutical Marketing Authorisation Strategy Course is a one-week advanced programme for pharmaceutical and biotechnology regulatory affairs professionals, submission managers, quality teams, market-access coordinators, legal and compliance professionals, and project leaders working with CIS markets. Participants build a CIS Authorisation Strategy Portfolio connecting jurisdiction and route mapping, EAEU medicinal product registration, national pathways, dossier evidence, language controls, submission readiness, authority interactions, response governance, lifecycle changes, regulatory intelligence, and cross-functional decisions. Agile Leaders Training Center treats the region as multiple legal and procedural environments, requiring current local verification and authorized advice; the course provides process education and no legal opinion, approval guarantee, or substitute for an authority’s current rules.

Who Should Attend

Pharmaceutical and biotechnology regulatory affairs professionals
Submission, dossier, and lifecycle managers
Quality, clinical, nonclinical, and pharmacovigilance contributors
Market-access, legal, compliance, and localization coordinators
Project leaders governing CIS and EAEU regulatory programmes

The course assumes experience in regulatory affairs, product development, quality, submissions, compliance, or market entry. Participants must verify current requirements, interpretations, fees, timelines, forms, representation rules, and language obligations with the responsible authority and qualified local advisers before acting.

Departments and Industries

The course supports organizations planning pharmaceutical or biotechnology authorization work across CIS jurisdictions and the EAEU common market.

Pharmaceutical and biotechnology companies
Regulatory affairs and product-registration functions
Quality, clinical, nonclinical, and pharmacovigilance teams
Legal, compliance, localization, and market-access functions
Contract research, consulting, and dossier-support organizations

Learning Objectives

By the end of this course, participants will be able to:

Distinguish CIS geographic scope, EAEU common procedures, and national authorization routes
Build a current-source jurisdiction and procedure map
Classify product, applicant, route, reference state, and target-market decisions
Structure a CIS pharmaceutical dossier course evidence and gap matrix
Plan language, translation, legalization, product-information, and labeling controls
Conduct submission-readiness, question-response, and authority-interaction governance
Plan pharmaceutical variations and renewals with lifecycle calendars
Maintain CIS regulatory intelligence, risk, decision, and accountability registers

Course Agenda

Day 1: Jurisdiction, Authority, and Route Strategy

CIS Market and Jurisdiction Scope Map
EAEU and National Procedure Boundary
Responsible Authority and Current-Source Register
Product, Applicant, and Route Classification
Reference-State and Target-Market Decision Record

Day 2: Dossier and Evidence Strategy

Dossier Structure and Content Map
Quality, Nonclinical, Clinical, and Safety Evidence Matrix
Biological and High-Technology Product Considerations
Gap, Dependency, Owner, and Due-Date Register
Inspection and Quality-System Readiness Dependencies

Day 3: Language, Product Information, and Submission Readiness

Language, Translation, Certification, and Legalization Plan
Product Information, Patient Leaflet, Labeling, and Packaging Control
Electronic Application and Administrative Document Checklist
Submission Readiness and Technical Validation Review
Version, Document, and Evidence Traceability

Day 4: Review, Questions, and Authority Interaction

Examination and Review Milestone Map
Authority Question Intake and Triage
Response Evidence, Review, Approval, and Submission Workflow
Commitment, Inspection, Deficiency, and Escalation Log
Agency Interaction and Decision Record

Day 5: Lifecycle Governance and Regulatory Intelligence

Variation, Re-registration, Renewal, and Maintenance Calendar
Post-Authorization Information and Labeling Change Control
CIS Regulatory Intelligence Course Monitoring Register
Cross-Functional Risk and Governance Review
Capstone: CIS Authorisation Strategy Portfolio

Practical Exercises

The course uses fictional regulatory scenarios and requires participants to verify every live requirement through current authoritative sources.

Suggested activity: classify a product and map EAEU and national procedure options.
Suggested activity: build a dossier evidence, language, and readiness matrix.
Suggested activity: govern an authority question from intake through approved response.
Suggested activity: create a lifecycle calendar and regulatory-intelligence decision brief.

FAQs

Who should attend a CIS pharmaceutical marketing authorisation course?

It suits experienced regulatory affairs, submission, quality, clinical, safety, legal, compliance, localization, market-access, and project professionals working with pharmaceuticals or biotechnology products.

Is there one marketing-authorisation route for all CIS markets?

No. The course begins with jurisdiction and route mapping. Teams distinguish EAEU common procedures from national routes and verify current scope, authority, forms, evidence, languages, representation, and lifecycle requirements for each intended market.

What does EAEU medicinal product registration involve?

The course examines process planning for registration and examination, dossier structure, reference and target-market choices, mutual-recognition concepts, product information, authority questions, and lifecycle procedures. It does not interpret law for a live application.

Does the course cover biotechnology products?

Yes, at the strategy and governance level. Participants identify additional product classification, evidence, quality, inspection, and dossier dependencies and refer detailed scientific and legal decisions to authorized specialists.

What practical outputs will participants complete?

Outputs include a jurisdiction map, source register, route record, dossier matrix, language plan, readiness checklist, response workflow, interaction log, lifecycle calendar, intelligence register, risk review, and strategy portfolio.

credits: 5 credit per day

Course Mode: full-time

Provider: Agile Leaders Training Center

Download Brochure (PDF) Print PDF

Showing 41-60 of 75 events

Location	Dates	Duration	Mode	Price
Manama	Week 18, 2027 9 – 13 May 2027	1 Week	Onsite	€4,700
Sharm El-Sheikh	Week 19, 2027 10 – 14 May 2027	1 Week	Onsite	€4,100
Berlin	Week 20, 2027 17 – 21 May 2027	1 Week	Onsite	€5,700
Kuwait	Week 20, 2027 23 – 27 May 2027	1 Week	Onsite	€5,500
Dubai	Week 22, 2027 31 May – 4 June 2027	1 Week	Onsite	€4,500
Lisbon	Week 22, 2027 31 May – 4 June 2027	1 Week	Onsite	€5,700
Athens	Week 23, 2027 7 – 11 June 2027	1 Week	Onsite	€6,700
New York	Week 24, 2027 14 – 18 June 2027	1 Week	Onsite	€12,000
Tashkent	Week 24, 2027 20 – 24 June 2027	1 Week	Onsite	€4,500
Kuala Lumpur	Week 26, 2027 28 June – 2 July 2027	1 Week	Onsite	€5,200
Porto	Week 26, 2027 28 June – 2 July 2027	1 Week	Onsite	€5,700
Milan	Week 27, 2027 5 – 9 July 2027	1 Week	Onsite	€5,700
Johannesburg	Week 27, 2027 11 – 15 July 2027	1 Week	Onsite	€4,500
Casablanca	Week 29, 2027 19 – 23 July 2027	1 Week	Onsite	€4,100
Abu Dhabi	Week 29, 2027 19 – 23 July 2027	1 Week	Onsite	€4,700
Amsterdam	Week 30, 2027 26 – 30 July 2027	1 Week	Onsite	€5,700
Langkawi	Week 30, 2027 1 – 5 August 2027	1 Week	Onsite	€6,000
Dubai	Week 32, 2027 9 – 13 August 2027	1 Week	Onsite	€4,500
Madrid	Week 32, 2027 9 – 13 August 2027	1 Week	Onsite	€5,700
Rome	Week 33, 2027 16 – 20 August 2027	1 Week	Onsite	€5,700

Frequently asked questions

What does this course cover?

OverviewCIS Pharmaceutical Marketing Authorisation Strategy Course is a one-week advanced programme for pharmaceutical and biotechnology regulatory affairs professionals, submission managers, quality teams, market-access coordinators, legal and compliance professionals, and project leaders working with CIS markets. Participants build a CIS Authorisation S…

Are training dates available?

Yes. Available dates and destinations are listed in the course dates section on this page.

How can I register?

Choose an available date on this page and complete the registration form, or send a programme enquiry.

Can I download the course brochure?

Yes. Use the brochure download link provided on this page.

CIS Pharmaceutical Marketing Authorisation Course